Agronomics (LSE:ANIC) announced that its portfolio company Liberation Labs has formed a manufacturing partnership with Dutch startup Vivici. Liberation Labs will produce Vivici's flagship ingredient, Vivitein™ BLG, a dairy protein made through precision fermentation, at its Richmond, Indiana facility starting in 2026. The facility, currently in late-stage construction, features a 600,000-liter capacity with dedicated downstream processing. Agronomics has invested US$27 million in Liberation Labs, with the position currently valued at £34.1 million, representing ~23% of Agronomics' Net Asset Value as of December 2024. The partnership aims to address growing protein demand in the US market, enabling the production of innovative products like clear protein drinks, protein powders, and vegan-friendly protein bars.
Agronomics (LSE:ANIC) ha annunciato che la sua società in portafoglio Liberation Labs ha stretto una partnership produttiva con la startup olandese Vivici. Liberation Labs produrrà l'ingrediente di punta di Vivici, Vivitein™ BLG, una proteina del latte ottenuta tramite fermentazione di precisione, presso il suo stabilimento di Richmond, Indiana, a partire dal 2026. L'impianto, attualmente in fase avanzata di costruzione, ha una capacità di 600.000 litri con processi di lavorazione a valle dedicati. Agronomics ha investito 27 milioni di dollari in Liberation Labs, con una valutazione attuale della posizione pari a 34,1 milioni di sterline, rappresentando circa il 23% del valore netto degli asset di Agronomics a dicembre 2024. La collaborazione punta a soddisfare la crescente domanda di proteine nel mercato statunitense, permettendo la produzione di prodotti innovativi come bevande proteiche trasparenti, polveri proteiche e barrette proteiche vegane.
Agronomics (LSE:ANIC) anunció que su empresa en cartera Liberation Labs ha establecido una asociación de fabricación con la startup holandesa Vivici. Liberation Labs producirá el ingrediente principal de Vivici, Vivitein™ BLG, una proteína láctea obtenida mediante fermentación de precisión, en su planta de Richmond, Indiana, a partir de 2026. La instalación, actualmente en fase avanzada de construcción, cuenta con una capacidad de 600.000 litros y procesamiento downstream dedicado. Agronomics ha invertido 27 millones de dólares en Liberation Labs, con una valoración actual de la posición de 34,1 millones de libras, representando aproximadamente el 23% del valor neto de activos de Agronomics a diciembre de 2024. La asociación tiene como objetivo responder a la creciente demanda de proteínas en el mercado estadounidense, posibilitando la producción de productos innovadores como bebidas proteicas claras, polvos de proteína y barras proteicas aptas para veganos.
Agronomics(LSE:ANIC)는 자회사 Liberation Labs가 네덜란드 스타트업 Vivici와 제조 파트너십을 체결했다고 발표했습니다. Liberation Labs는 2026년부터 인디애나주 리치몬드에 위치한 시설에서 정밀 발효를 통해 만든 유제품 단백질인 Vivici의 주력 성분 Vivitein™ BLG를 생산할 예정입니다. 현재 건설 막바지 단계에 있는 이 시설은 60만 리터 용량과 전용 다운스트림 가공 설비를 갖추고 있습니다. Agronomics는 Liberation Labs에 2,700만 달러를 투자했으며, 이 지분은 2024년 12월 기준 약 3,410만 파운드로 평가되어 Agronomics 순자산가치의 약 23%를 차지합니다. 이번 파트너십은 미국 시장에서 증가하는 단백질 수요를 충족시키고, 투명 단백질 음료, 단백질 파우더, 비건 친화적 단백질 바와 같은 혁신 제품 생산을 가능하게 하는 것을 목표로 합니다.
Agronomics (LSE:ANIC) a annoncé que sa société en portefeuille Liberation Labs a conclu un partenariat de fabrication avec la startup néerlandaise Vivici. Liberation Labs produira l'ingrédient phare de Vivici, Vivitein™ BLG, une protéine laitière obtenue par fermentation de précision, dans son usine de Richmond, Indiana, à partir de 2026. L'installation, actuellement en phase finale de construction, dispose d'une capacité de 600 000 litres avec un traitement en aval dédié. Agronomics a investi 27 millions de dollars dans Liberation Labs, avec une valorisation actuelle de la position à 34,1 millions de livres, représentant environ 23 % de la valeur nette des actifs d'Agronomics en décembre 2024. Ce partenariat vise à répondre à la demande croissante en protéines sur le marché américain, permettant la production de produits innovants tels que des boissons protéinées transparentes, des poudres de protéines et des barres protéinées adaptées aux végétaliens.
Agronomics (LSE:ANIC) gab bekannt, dass seine Portfoliogesellschaft Liberation Labs eine Produktionspartnerschaft mit dem niederländischen Startup Vivici eingegangen ist. Liberation Labs wird Vivicis Hauptbestandteil, Vivitein™ BLG, ein Milchprotein, das durch Präzisionsfermentation hergestellt wird, ab 2026 in seiner Anlage in Richmond, Indiana, produzieren. Die Anlage, die sich derzeit in der Endphase des Baus befindet, verfügt über eine Kapazität von 600.000 Litern sowie eine dedizierte nachgelagerte Verarbeitung. Agronomics hat 27 Millionen US-Dollar in Liberation Labs investiert, wobei die Position aktuell mit 34,1 Millionen Pfund bewertet wird und etwa 23 % des Nettovermögenswerts von Agronomics im Dezember 2024 ausmacht. Die Partnerschaft zielt darauf ab, die wachsende Proteinnachfrage auf dem US-Markt zu bedienen und die Produktion innovativer Produkte wie klare Protein-Drinks, Proteinpulver und vegane Proteinriegel zu ermöglichen.
Positive
First commercial contract secured by Liberation Labs for its precision fermentation facility
Partnership expands production capabilities into the US market with 600,000-liter capacity
Vivici's product has received full FDA approval in the US
Agronomics' investment in Liberation Labs has appreciated to £34.1M from US$27M investment
Negative
Commercial production won't begin until 2026
Facility is still under construction, presenting potential timeline risks
DOUGLAS, ISLE OF MAN / ACCESS Newswire / May 8, 2025 / Agronomics (LSE:ANIC), a leading listed company in the field of clean food, is delighted to announce that its portfolio company, Liberation Labs Holdings Inc. ("Liberation Labs") has announced a manufacturing partnership with Dutch ingredients startup Vivici ("Vivici").
Jim Mellon, Executive Chair of Agronomics, said: "Global protein demand is outstripping supply, and there is a growing need from food companies to invest in alternatives which are scalable and sustainable. Companies like Vivici, which have received full FDA approval in the US and have strong financial backing, are ideal partners. Liberation Labs has made tremendous commercial strides in 2025, as it establishes itself as the global partner in commercialising bioproducts, from foods to materials and more. On the back of the fundraise announced at the start of the year, the signing of the first commercial contract is a significant step from Mark and the team in the successful execution of the company's commercial strategy."
To date, Agronomics has invested a total of US$ 27 million (c.£21.9 million) in Liberation Labs which, subject to audit, is currently carried at £34.1 million. This position represents c.23% of Agronomics' last stated Net Asset Value as at 31 December 2024.
The full announcement is set out below without any material changes
RICHMOND, Ind. (May 7, 2025) Liberation Labs today announced a manufacturing partnership with Dutch ingredients startup Vivici. Liberation Labs will produce Vivici's flagship ingredient, ViviteinTM BLG, at its Richmond, Indiana facility when commercial production begins in 2026.
The New Standard of Protein, Vivitein™ BLG is a dairy protein (beta-lactoglobulin) produced through precision fermentation enabling B2B customers to launch disruptive, differentiated and better overall products to consumers in the US market. These include clear water-based protein drinks with innovative flavors, clean protein powders with superior muscle-building performance and rapid absorption and vegan-friendly protein bars with luscious chewy textures.
"Vivici is a perfect reference case for our facility - a company seeking cost-effective and sustainable manufacturing of a novel protein ingredient that unlocks a range of other healthy and innovative products," said Mark Warner, founder and CEO of Liberation Labs. "We love what Vivici is doing and will be proud to play a role in their success."
Liberation Labs is in the late stages of constructing its first commercial-scale, purpose-built, precision fermentation biomanufacturing facility with a capacity of 600,000 liters and a fully dedicated downstream process. The plant will produce a range of bio-based materials, including building block ingredients for food, chemicals and other industrial products at a scale and cost that will fill a pressing need among both new and established consumer packaged goods companies and other industrial manufacturers.
"As awareness of the important role protein plays in supporting active lifestyles continues to grow, American consumers are demanding higher quality and greater quantities of protein in their diets." said Stephan van Sint Fiet, CEO of Vivici. "Our partnership with Liberation Labs expands our European manufacturing capabilities, providing US customers with increased supply security for Vivitein™ BLG."
About Liberation Labs
Liberation Labs is commercializing precision fermentation with a global network of purpose-built manufacturing facilities that enable the next wave of biotechnology advancements to produce bio-based consumer products at scale. We combine modern technology with fit-for-purpose design to bring reliable and cost-effective solutions that meet customer demand across the world. Our flagship facility in Richmond, Indiana is expected to begin production in 2026 and we have begun a feasibility study for a second plant in Saudi Arabia. More information is available at www.liberationlabs.com.
This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
What is the manufacturing partnership between Liberation Labs and Vivici?
Liberation Labs will produce Vivici's Vivitein™ BLG, a dairy protein made through precision fermentation, at its Richmond, Indiana facility starting in 2026.
How much has Agronomics (AGNMF) invested in Liberation Labs?
Agronomics has invested US$27 million (£21.9 million) in Liberation Labs, with the position currently valued at £34.1 million, representing 23% of Agronomics' Net Asset Value.
What is the production capacity of Liberation Labs' Richmond facility?
The facility has a capacity of 600,000 liters and includes a fully dedicated downstream process for producing bio-based materials.
What products will be made using Vivici's Vivitein™ BLG protein?
Vivitein™ BLG will be used in clear water-based protein drinks, clean protein powders for muscle building, and vegan-friendly protein bars.
When will Liberation Labs begin commercial production for Vivici?
Commercial production at the Richmond, Indiana facility is scheduled to begin in 2026.
An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
